Teriparatide is used for reducing the risk of bone fractures in post-menopausal women with osteoporosis. It was first introduced by Eli Lilly And Co in its drug Forteo on Nov 26, 2002. Other drugs containing Teriparatide are Bonsity, Teriparatide. 5 different companies have introduced drugs containing Teriparatide.

Teriparatide Patents

Given below is the list of patents protecting Teriparatide, along with the drug name that holds that patent and the company name owning that drug.

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Forteo	US7517334	Medication dispensing apparatus with spring-driven locking feature enabled by administration of final dose	Mar 25, 2025 (Expired)	Lilly
Forteo	US6977077	Method of increasing bone toughness and stiffness and reducing fractures	Aug 19, 2019 (Expired)	Lilly
Forteo	US7163684	Method of increasing bone toughness and stiffness and reducing fractures	Aug 19, 2019 (Expired)	Lilly
Forteo	US7351414	Method of reducing the risk of bone fracture	Aug 19, 2019 (Expired)	Lilly
Forteo	US6770623	Stabilized teriparatide solutions	Dec 08, 2018 (Expired)	Lilly
Forteo	US7144861	Stabilized teriparatide solutions	Dec 08, 2018 (Expired)	Lilly
Forteo	US7550434	Stabilized teriparatide solutions	Dec 08, 2018 (Expired)	Lilly

Add above patents to watchlist

Teriparatide's Family Patents

Unlock Global Patents

Teriparatide Generic API Manufacturers

Several generic applications have been filed for Teriparatide. The first generic version for Teriparatide was by Teva Pharmaceuticals Usa Inc and was approved on Nov 16, 2023. And the latest generic version is by Apotex Inc and was approved on Nov 16, 2023.

Given below is the list of companies who have filed for Teriparatide generic, along with the locations of their manufacturing plants worldwide.